| 注册
首页|期刊导航|中国医药科学|孟鲁司特和舒利迭联合治疗中重度慢阻肺非急性发作期的效果分析

孟鲁司特和舒利迭联合治疗中重度慢阻肺非急性发作期的效果分析

李永兰

中国医药科学Issue(16):54-56,3.
中国医药科学Issue(16):54-56,3.

孟鲁司特和舒利迭联合治疗中重度慢阻肺非急性发作期的效果分析

Analysis of curative effect of montelukast combined with seretide in the treatment of non-acute attack of moderately severe COPD

李永兰1

作者信息

  • 1. 四川省都江堰市中医医院肺病科,四川都江堰 611830
  • 折叠

摘要

Abstract

ObjectiveTo explore the curative effect of montelukast combined with seretide in the treatment of non-acute attack of moderately severe COPD. Methods122 patients with non-acute attack of moderately severe COPD were randomly allocated to an observation group of 61 patients and a control group of 61 patients. The control group was received seretide treatment, while the observation group was received montelukast combined with seretide treatment. The curative effect of two groups were observed.ResultsFVC, EFV1 and FVC% in observation group were all significantly higher than those in control group after treatment (P<0.05). MRC score of observation group was lower than that of control group, and ADL score was higher than that of control group (P<0.05). PH, PaO2 and PaCO2 of observation group were all better than those of control group (P<0.05). ConclusionMontelukast combined with seretide has a positive curative effect in the treatment of moderately severe COPD, which has a better prospect of application.

关键词

慢性阻塞性肺疾病/孟鲁司特/舒利迭/肺功能

Key words

COPD/Montelukast/Seretide/Pulmonary function

分类

医药卫生

引用本文复制引用

李永兰..孟鲁司特和舒利迭联合治疗中重度慢阻肺非急性发作期的效果分析[J].中国医药科学,2015,(16):54-56,3.

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文